Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about $4.9 billion
from Latest News https://ift.tt/3zi3Nxo
Thursday, 16 September 2021
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment